Peptide Factory99% White Powder High Pure Quality Semaglutide Weight Loss SM5 SM10 SM15 SM20 SM30
62 Inquiries
89030-95-5
Pharmaceutical Grade
99%
GuangZhou
YingHui
10mg/vial,10vials/box
2026-06-25
Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCopper Tripeptide is a tripeptide molecule rich in copper ions. Its sequence is GHK and it is widely present in human blood, saliva and urine. With age, the concentration of GHK gradually decreases, which is related to the decline of organ regeneration ability. Copper Tripeptide has strong antioxidant capacity, neutralizes free radicals, protects the skin from environmental damage, and with its unique copper ion affinity, it plays a role in promoting wound healing and activating skin regeneration.
Copper tripeptide, also known as [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper or GHK-Cu, is a naturally occurring tripeptide. It was first isolated from human plasma but can be found in saliva and urine. During wound healing, it may be freed from existing extracellular proteins via proteolysis. Studies have shown that GHK-Cu has a maximal biological effect at 10-9mol/L and Its concentration in the body decreases with age[1].Basic Info-
Product Name:
Copper tripeptide
Other Name:[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;Ghk-Cu/AHK-CU;Copper tripeptide (GHK-Cu);Prezatide copper,[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;tripeptide/GHK-Cu;Copper peptide, GHK-Cu, Copper tripeptide-1;GHK Copper;GHK.CU.HAC
CAS No.:89030-95-5
Molecular Formula:C14H21CuN6O4
InChIKeys:DDNUEECOCUBKBT-MIIMWFGWNA-L
Molecular Weight:400.91
Exact Mass:402.10800
EC Number:1308068-626-2
Color/Form:Light blue to blue
Categories:
Characteristics-
PSA:
186.03000
XLogP3:1.04530
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide
-
Location:
Lobby of Area B, Area E, Area F and Area G (Central Office Area), Landao Research Center, No.3 Yingbin Road, Yangpu Economic Development Zone, Hainan Province
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
3
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2025
-
Certifications:
Retatrutide,Retatrutide,Retatrutide,Retatrutide
-
-
Inquiry History62 Inquiries
Country Product Purchase Quantity Date Posted 
Malaysia
Peptide GHK-Cu Copper Tripeptide-1 Powder CAS 89030-95-5
10 MG Apr 24, 2025 
United States
GhkCu
5 G Aug 5, 2026
United States
ghkcu
10 MG Jul 29, 2026 
Philippines
Ghkcu
20 Jul 28, 2026
United States
Ghk cu
12 Jul 8, 2026
United States
ghk cu
1 G Jun 12, 2026
United States
Ghk cu
5 MT Jun 11, 2026 
Netherlands
ghk-cu
50 MG May 19, 2026 
United Kingdom
ghk cu
500 MT Apr 26, 2026
United States
GKHcu
1 G Apr 24, 2026 
Canada
ghk cu
1 G Mar 30, 2026
United States
Ghk cu
1 KG Mar 18, 2026 
Australia
Ghk Cu
1 KG Feb 2, 2026
Canada
GHK-CU
50 MG Jan 26, 2026
United States
Ghk cu copper peptide
500 MG Dec 8, 2025
United States
GHK-CU Raw
1 G Nov 12, 2025 
Latvia
GHK-Cu tripeptide
10 G Aug 4, 2025 
Israel
ghk-cu
5 20' Fcl Feb 28, 2024 
Hungary
Copper Tripeptide GHK-Cu AHK-Cu 98%
100 G Jan 24, 2024
Australia
Copper Tripeptide-1
1 KG Jan 9, 2024 Post an enquiry for this product
